Stay updated on Durvalumab & Tremelumab vs SoC in NSCLC Clinical Trial
Sign up to get notified when there's something new on the Durvalumab & Tremelumab vs SoC in NSCLC Clinical Trial page.

Latest updates to the Durvalumab & Tremelumab vs SoC in NSCLC Clinical Trial page
- Check2 days agoChange DetectedThe Record History adds a new revision entry (v3.5.4) and removes the previous v3.5.3, indicating an updated release of the page. This is a metadata update to the page version rather than a change to trial information.SummaryDifference0.1%

- Check9 days agoChange DetectedA new version entry on 2026-05-01 adds the Study Status to the study's Record History, following an update on 2026-04-30 that accounted for 55 changes. A deletion on 2026-02-12 removes an earlier history entry.SummaryDifference0.2%

- Check16 days agoChange DetectedA new revision entry labeled v3.5.3 is added to the record history, replacing the previous v3.5.2.SummaryDifference0.1%

- Check23 days agoNo Change Detected
- Check31 days agoChange DetectedAdded Revision: v3.5.2 to the history and removed Revision: v3.5.0.SummaryDifference0.1%

- Check52 days agoChange DetectedThe history now shows a new Revision: v3.5.0, replacing the previous Revision: v3.4.3.SummaryDifference0.1%

- Check66 days agoChange DetectedHistory shows a new revision entry v3.4.3 and removal of v3.4.2, indicating a small backend update to the page.SummaryDifference0.1%

Stay in the know with updates to Durvalumab & Tremelumab vs SoC in NSCLC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Durvalumab & Tremelumab vs SoC in NSCLC Clinical Trial page.